{"id":"clm_BA7FB06172CD","entity":"eli-lilly","predicate":"total_equity","value":"17,983,700,000 United States dollar","value_json":{"fp":"Q2","fy":2014,"accn":"0000059478-14-000129","form":"10-Q","filed":"2014-07-28","period":"Q2 FY2014","concept":"us-gaap:StockholdersEquity"},"valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Eli Lilly and Company total equity: 17,983,700,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_BA7FB06172CD, https://asof.is/claim/clm_BA7FB06172CD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947814000129/0000059478-14-000129-index.htm.","url":"https://asof.is/claim/clm_BA7FB06172CD","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_570B41055A07","supersedes":["clm_06455B93E953"],"first_seen_at":"2026-11-08T15:32:10.500298+00:00","updated_at":"2026-11-08T15:32:18.231201+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000129/0000059478-14-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-07-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2014, filed 2014-07-28"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}